GeneSight Mental Health Monitor Media Kit

GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care

Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care

The GeneSight Mental Health Monitor is a nationwide survey of U.S. adults conducted online by ACUPOLL Precision Research, Inc. from Aug. 16 – 30, 2022, among a statistically representative sample (n=1000) of adults age 18+. The survey included a representative sample of women diagnosed with depression and anxiety.

Previous releases

graphic of drawing of woman doctor with text “67% of women diagnosed wished their doctor had told them about genetic testing for medication outcomes”

2 Out of 3 Women With Depression or Anxiety Say They’ve Reached Their “Breaking Point,” Yet More than Half Wait a Year Before Seeking Treatment

Six in 10 of the women surveyed with depression or anxiety diagnosis say they have been ignored or dismissed by family, friends, and/or partners about their mental health concerns

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

Now is the time when people start to think of new year’s resolutions to improve their health. For many, the focus is on physical goals like losing weight or exercising more. A nationwide survey suggests that many may want to consider adding mental health resolutions to their list.

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

GeneSight Mental Health Monitor finds many parents struggle to know the difference between teenage behavior and a mental health challenge

One of the biggest issues parents of teenagers may face is determining if their child is
experiencing a mental health challenge or ordinary “growing pains.”

Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey

Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they won’t seek treatment for mental health conditions and others say they won’t get help until these symptoms take a toll in their lives.

Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey

Depression medication trial and error is far too common – and may result in additional
mental health challenges.

New research reveals most Americans can’t identify the symptoms of depression

GeneSight® Mental Health Monitor finds large gap between what Americans think and what they actually know about recognizing depression

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine,
today announced results from a recent nationwide poll, the GeneSight® Mental Health Monitor.

Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment

New poll shows 83% of people with depression agree life would be easier if others could understand their depression

In a new nationwide poll, the GeneSight® Mental Health Monitorfound that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment.

Experiencing Depression

To help others understand how depression feels, click on the thumbnail below to visit a virtual experience.

Dark messy bedroom representing how depression feels